MAPT and Alzheimer disease: The combination of disturbed Aβ metabolism with other typical hallmarks of AD, e.g., the characteristic Tau pathology, might model the complex pathology more comprehensively, as it has been attempted in older transgenic models such as the 3xTg-AD mouse model.